The basal cell state maintains pancreatic cancers by controlling an immunosuppressive circuit
Anupriya SinghaliD, Kate Ryan, Samuel Rose, Hannah C. StyersiD, Jung Kim, Nikhita Pasnuri, Ashlyn Moore, Jose Llamosas, Emily Chen, Josephine AdamsiD, Ananya Nandula, Roshan Sharma, Zhuxuan LiiD, Tal NawyiD, Yan YaniD, Nuray TezcaniD, Olca Basturk, Mara H. ShermaniD, Dana Pe’eriD, Tuomas TammelaiD
Abstract
Intra-tumoral heterogeneity is a cardinal feature of solid tumors, yet how distinct cancer cell states functionally contribute to malignant and stromal diversity in situ remains poorly understood. Using mouse models to lineage-trace or genetically ablate the two predominant cancer cell states in autochthonous pancreatic ductal adenocarcinoma (PDAC), we discover that basal cancer cells are highly plastic, whereas classical cancer cells exhibit limited plasticity. Strikingly, ablation of the basal, but not the classical, state induced rapid and durable tumor collapse, driven by loss of immunosuppressive cancer-associated fibroblasts, macrophage repolarization, and reprogramming of the tumor cytokine milieu, culminating in tumor destruction by cytotoxic lymphocytes. Knockout of a single cytokine, GM-CSF, specifically in basal cells recapitulated macrophage repolarization and lymphocyte recruitment observed upon basal state ablation and shrank tumors. These results reveal the basal cell state controls an immunosuppressive cell circuit critical for PDAC maintenance, motivating therapeutic targeting of the basal cells.
02 /Specification & Classification
Click any tag to browse matching papersReproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cancer associated fibroblasts drive epithelial to mesenchymal transition and classical to basal change in pancreatic ductal adenocarcinoma cells with loss of IL-8 expression
Samantha R. Guinn, Brayan Perez, … Jacquelyn W. Zimmerman·bioRxiv·Jan 7, 2025
- Notch signaling regulates immunosuppressive tumor-associated macrophage function in pancreatic cancer
W. Yan, N. G. Steele, … F. Bednar·bioRxiv·Jan 11, 2023
- Myc inhibition triggers GM-CSF-driven regression of pancreatic tumours
Tania Campos, Roderik M. Kortlever, … GI EVAN·bioRxiv·Feb 25, 2026
- Single-cell immune multi-omics and repertoire analyses in pancreatic ductal adenocarcinoma reveal differential immunosuppressive mechanisms within different tumour microenvironments
S. Sivakumar, A. Jainarayanan, … R. J. M. Bashford-Rogers·bioRxiv·Aug 31, 2023
- Tumor-specific CD4 T cells instruct monocyte differentiation in pancreatic ductal adenocarcinoma
M. T. Patterson, A. L. Burrack, … I. M. Stromnes·bioRxiv·Nov 9, 2022
- Macrophage proliferation machinery leads to PDAC progression, but susceptibility to innate immunotherapy.
D. G. DeNardo, C. Zuo, … J. D. Weber·bioRxiv·Nov 8, 2021